Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
You're receiving the same pharmaceutical-grade peptides and expert medical supervisionjust at fair, honest pricing
That's why I want to help people feel better first
After 30 days, even refrigerated peptides begin losing potency measurably
US$ 29.33
US$ 22.25
US$ 26.36
US$ 22.79
US$ 23.95
US$ 27.05
US$ 29.23
US$ 28.26
US$ 25.69
US$ 22.84
US$ 25.21
US$ 21.74
US$ 28.28
